MedTrace Logo

Non-Pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions

NCT02393053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-03-19

No results posted yet for this study

Summary

Background: This randomized controlled clinical study of split-mouth aimed to compare non-pedicled buccal fat pad graft (BFPG) with subepithelial connective tissue graft (SCTG) in the treatment of Miller Class I or II gingival recessions.

Methods: Twelve patients with Miller Class I or II (≥ 2 mm) bilateral recessions in maxillary premolars or canines were selected. The recessions were randomly assigned to receive SCTG (Control Group) or BFPG (Test Group). The clinical parameters of Gingival Index (GI), Plaque Index (PI), Probing Depth (PD), Gingival Recession (GR), Clinical Attachment Level (CAL), Width of Keratinized Tissue (WKT), Thickness of Keratinized Tissue (TKT) and Gingival Margin to the Acrylic Guide (GM-AG) were evaluated at baseline, and in the postoperative periods of 1, 3, and 6 months. The percentage of root coverage was also evaluated. Data were submitted to repeated measures ANOVA, Bonferroni method and t-test (p\<0.05).

Conditions

  • Gingival Recession

Interventions

PROCEDURE

Treatment with subepithelial connective tissue graft (SCTG)

Miller Class I or II gingival recessions were treated with subepithelial connective tissue graft (SCTG)

PROCEDURE

Treatment with non-pedicled buccal fat pad graft (BFPG)

Miller Class I or II gingival recessions were treated with non-pedicled buccal fat pad graft (BFPG)

Sponsors & Collaborators

  • Universidade Positivo

    lead OTHER

Principal Investigators

  • Flares Baratto Filho, PhD · Universidade Positivo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-02-28
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02393053 on ClinicalTrials.gov